Awan FT, Yande S, Esterberg L, Nagar SP, Goyal RK, Priyadarshini M. Economic burden in patients (pt) with CLL/SLL (CLL) who received ≥ 2 prior lines of therapy (LOT), including a Bruton tyrosine kinase inhibitor (BTKi): a SEER-Medicare analysis. Poster presented at the ASCO Quality Care Symposium 2023; October 27, 2023. Boston, MA. [abstract] JCO Oncol Pract. 2023 Nov 1; 19(11 Suppl):23-4. doi: 10.1200/OP.2023.19.11_suppl.24
Gnanasakthy A, Norcross L, Clark M, Fitzgerald K. A review of patient-reported outcome considerations in oncologic drug advisory committee meetings (2016-2021). JCO Oncol Pract. 2023 May;19(5):e745-62. doi: 10.1200/OP.22.00774
Witherspoon DP, Wei W, May EM, Boggs S, Chancy D, Bamaca-Colbert MY, Bhargava S. Latinx youth's ethnic-racial identity in context: examining ethnic-racial socialization in a new destination area. J Soc Issues. 2021 Dec 22;77(4):1234-56. doi: 10.1111/josi.12492
Madrigal C, Fick D, Mogle J, Hill NL, Bratlee-Whitaker E, Belser A. Disrupting younger adults' age-based stereotypes: The impact of an intergenerational artistic installation. J Inter Relation. 2020 Jan 21;18(4):399-416. doi: 10.1080/15350770.2020.1713960